✦ LIBER ✦

Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome

✍ Scribed by Prakash C Deedwania; Donald B Hunninghake; Harold Bays

Book ID: 113440922
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 237 KB
Volume: 93
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2004.02.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolic Syndrome and Vascular Alterati

Metabolic Syndrome and Vascular Alterations in Normotensive Patients at Risk of Diabetes Mellitus

✍ C. Giannarelli; Y. Plantinga; L. Ghiadoni; G. Penno; A. Salvetti; S. Del Prato 📂 Article 📅 2007 🏛 Atlantis Press 🌐 English ⚖ 49 KB

MS514 PREMATURE TREATMENT EFFECTS OF MET

MS514 PREMATURE TREATMENT EFFECTS OF METABOLIC SYNDROME AS THE PREDICTOR OF DIABETES MELLITUS TYPE 2

✍ Gamezardashvili, T.; Kipshidze, N. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Prevalence of diabetes mellitus and meta

Prevalence of diabetes mellitus and metabolic syndrome in Slovakia

✍ Marián Mokáň; Peter Galajda; Dana Prídavková; Viera Tomášková; Ľudovít Šutarík; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Laparoscopic treatment of metabolic synd

Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus

✍ A. L. DePaula; A. L. V. Macedo; N. Rassi; S. Vencio; C. A. Machado; B. R. Mota; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB

Laparoscopic treatment of metabolic synd

Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus

✍ A. L. DePaula; A. L. V. Macedo; N. Rassi; S. Vencio; C. A. Machado; B. R. Mota; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB

Glucocorticoids in type 2 diabetes melli

Glucocorticoids in type 2 diabetes mellitus and the metabolic syndrome

✍ Bernice Welles 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

## Abstract While glucocorticoids were originally named for their role in glucose metabolism, their role in many aspects of resting and stress‐related homeostasis has been elucidated. An accumulation of evidence linking abnormal glucocorticoid metabolism to both type 2 diabetes and metabolic syndro